Perioperative management of antiplatelet agents in general and visceral surgery: a pilot study

Conditions

Surgical complication rates, thromboembolic events Not Applicable

Hiroki Ohya, Jun Watanabe, Yusuke Suwa, Kazuya Nakagawa, Hirokazu Suwa et al. (9 authors)

Annals of Gastroenterological Surgery2020-10-2811 citations

A randomised controlled trial to evaluate and optimize the use of antiplatelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007).

Antolovic D, Reissfelder C, Rakow A, Contin P, Rahbari NN, Büchler MW, Weitz J, Koch M.

2011-03-036 citations

10.1186/1471-2482-11-7

Interventions

In the pilot phase, we provide low-risk patients with acetylsalicylic acid (ASA) 100 mg/day. There are two arms of randomisation: discontinuation versus continuation of aspirin. Patients stop 5 days b

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Cardiac low and medium risk patients with antiplatelet agents 2. Informed consent 3. Aged over 18 years, either sex 4. Physical and psycological ability to participate in the trial

Exclusion criteria

Exclusion criteria: 1. Cardiac high risk patients 2. Psychiatric disorder 3. No informed consent

Design outcomes

Primary

Measure	Time frame
1. Bleeding complications 2. Thromboembolic events	—

Secondary

Measure	Time frame
1. Duration of surgery 2. Blood loss during surgery 3. Complication rate 4. Length of hospital stay 5. Readmission to hospital after discharge 6. Difference between laparoscopic versus open surgery	—

Countries

Germany

Outcome results

None listed